Pharma organizations are investing heavily in AI, yet many are still operating within agency models built for a different era. As AI becomes more embedded across pharmaceutical commercialization, a new question is emerging:
Are today’s agency structures designed to capture its full value?
This POV examines how AI is reshaping the assumptions traditional agency models were built on and why the future may require a different approach to how agencies and marketers create value together. As organizations explore more connected approaches to commercialization, many are also evaluating how platforms like EVERSANA’s AI Agency Platform can help support end-to-end execution, compliance and customer engagement.
You’ll explore:
- Why traditional agency models limit AI’s potential
- How AI is redefining the agency relationship and commercial operating model
- The leadership questions organizations must answer before AI can deliver its full value
Download the full POV.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…